The Effects of Different Vibration Exercises on COPD Patients
Condition(s) studied
Investigational drug(s) / intervention(s)
Whole-body Vibration Therapy: Each session includes six series, each lasting 2 minutes, with a frequency of 35 Hz and an amplitude of 2 mm, with a 60-second rest interval between series. For the starting position, the patient stands relaxed on the platform, holding the WBV platform handles.
Local Vibration Therapy: Each session includes six series, each lasting 2 minutes, with a frequency of 35 Hz and an amplitude of 2 mm, with a 60-second rest interval between series. After the warm-up exercise, the researcher helps the patient wear the localized vibration instrument. During the vibration, participants will hold onto the handle to ensure balance stability.
Study summary
Pulmonary rehabilitation is effective in improving exercise tolerance, dyspnea, and fatigue in patients with COPD, and exercise training is an important component of pulmonary rehabilitation. Vibration training can be used as a supplement or alternative to traditional exercise and is a short, safe rehabilitation training.
COPD patients will be recruited and randomly assigned to the control group, whole-body vibration training group, or local vibration training group. The study aims to confirm the rehabilitative benefits of enhancing lower limb muscle strength, exercise endurance, and the quality of life related to COPD in patients.
Eligibility
Primary outcome measure(s)
- 6 Minute Walking Test — Base line, Week12, Week16
This test measures how far the patient can walk in 6 minutes, with a greater distance indicating better performance. - Maximal voluntary contraction force — Base line, Week12, Week16
The readings from the digital dynamometer can be converted into kilograms, with higher values indicating greater muscle strength.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Taipei Medical University WanFang Hospital | Taipei | Wenshan Dist | Recruiting |
More Taipei Medical University trials in Taiwan
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06413524 on ClinicalTrials.gov ↗ ← All trials in Taiwan